ScienceAlert on MSN
'Mammoth' Bones Kept in a Museum For 70 Years Turn Out to Be An Entirely Different Animal
The fossilized backbones of what appeared to be woolly mammoths have turned out to come from an entirely different and ...
Chandigarh: The year 2025–26 emerged as a landmark phase for Haryana's Forensic Science Laboratory (FSL) system, as ...
Triton has been a recongised agency in Indian advertising, known for building some of the country's most recognisable mass ...
Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.
The Stranger Things finale brought nearly ten years of supernatural adventure to a conclusion, leaving fans with mixed ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA.
Bionova Scientific LLC, an Asahi Kasei company and a bespoke contract development and manufacturing organization (CDMO), announced a strategic manufacturing alliance with Syenex, a genetic medicines ...
This might be the most famous modern Dateline case, and it even inspired the scripted series The Thing About Pam. In 2013, ...
3don MSN
How US Could Annex Greenland
President Donald Trump and his top officials have framed their drive for Greenland — a semi-autonomous Danish territory — as ...
Mongabay on MSN
An inventory of life in California
Why Mongabay is reporting on California’s biodiversity Mongabay’s coverage of biodiversity has long been associated with ...
GlobalData on MSN
GSK to file for approval of hep B drug on positive Phase III data
GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results